🇺🇸 FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11339387

Modified foot-and-mouth disease virus 3C proteases and methods for processing FMDV P1 prec

The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11338033

Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11337971

Dopamine D3 receptor selective antagonists/partial agonists and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11337988

Use of ouabain antagonists to inhibit viral infection

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11338032

Methods of preparing anti-human papillomavirus antigen T cells

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11339198

Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11331370

Combination product for the prevention of sexually transmitted infections

The United States of America · Granted Tue May 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11331385

Methods of preparing anti-human papillomavirus antigen T cells

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11332722

Development of dengue virus vaccine components

The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11332721

Recombinant respiratory syncytial virus strains with mutations in the M2-2 ORF providing a

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11325978

Compositions and methods for treating beta-globinopathies

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11325965

Single-domain VH H antibodies directed to norovirus GI.1 and GII.4 and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11324725

Compositions and methods for the inhibition of pruritus

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11318196

Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11311613

Development of agonist epitopes of the human papillomavirus

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11305009

Recombinant virus with diminished latency and methods of using same

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11306131

T cell receptors recognizing HLA-A1- or HLA-CW7-restricted mage

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11306132

HLA class II-restricted T cell receptors against mutated RAS

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11299546

FLT3-specific chimeric antigen receptors and methods using same

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11299476

Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use the

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11299517

Recombinant vaccine against Marek's disease and Newcastle disease

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Apr 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11293010

Methods of producing modified natural killer cells and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11285142

Compositions and methods for identifying and treating dystonia disorders

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11285169

Methods for modulating chemotherapeutic cytotoxicity

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted